Amrita Ahluwalia

Amrita Ahluwalia is a renowned pharmacologist and vascular biologist known for her significant contributions to the field of cardiovascular medicine. She is currently a Professor of Vascular Pharmacology at the William Harvey Research Institute, Queen Mary University of London, and a co-director of the Barts Centre for Hypertension.

Early Life and Education

Ahluwalia was born and raised in the United Kingdom. She completed her undergraduate studies in Pharmacology at the University of Sunderland, followed by a PhD in Pharmacology at the University of Cambridge.

Career

Following her PhD, Ahluwalia undertook postdoctoral research at the University of California, San Francisco (UCSF). She then returned to the UK and joined the William Harvey Research Institute, where she has remained since. Her research focuses on the mechanisms underlying the regulation of blood pressure and the development of novel therapeutic strategies for hypertension.

Ahluwalia's work has led to significant advancements in the understanding of the role of nitric oxide in blood pressure regulation. She has also been instrumental in the development of new drugs for the treatment of hypertension.

Awards and Honors

Ahluwalia has received numerous awards and honors for her work, including the British Pharmacological Society's Lilly Prize and the American Heart Association's Novartis Award. She is also a Fellow of the Royal Society of Biology and the British Pharmacological Society.

Publications

Ahluwalia has published extensively in the field of cardiovascular pharmacology. Her most notable publications include studies on the role of nitric oxide in blood pressure regulation and the development of new drugs for hypertension.

See Also

• Pharmacology
• Vascular Biology
• Hypertension
• William Harvey Research Institute
• Queen Mary University of London